PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Magnesium Hydroxide→

Magnesium Hydroxide PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1309-42-8
Molecular formula
Mg(OH)2
Molecular weight
58.32 g/mol
Drug class
Inorganic magnesium saltantacid and osmotic laxative
Mechanism of action
Neutralises gastric hydrochloric acid to reduce gastric acidity. In the intestine, unabsorbed magnesium ions retain water osmotically in the lumen, softening stool and promoting bowel movements.
Indications / reported uses
  • Short-term relief of occasional constipation in oral laxative formulations
  • Symptomatic relief of heartburn, acid indigestion and upset stomach in authorised antacid formulations; route and dose are product-specific

Sources: US DailyMed — Milk of Magnesia (magnesium hydroxide) · NLM MeSH — Magnesium hydroxide · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Magnesium Hydroxide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Magnesium Hydroxide Permitted Daily Exposure (PDE) report (the Magnesium Hydroxide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Magnesium Hydroxide Occupational Exposure Limit (OEL) report (the Magnesium Hydroxide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.